ETNA-MS Device Validation Study
NCT: NCT06256731 · COMPLETED
Brief Summary
The overarching goal of this research protocol is to validate the effectiveness of Innodem's ETNA-MS device in informing clinicians on the disability status of Multiple Sclerosis (MS) patients. Effectiveness of the device will be assessed by the level of agreement between the EDSS estimated by the device and the actual scores measured by the neurologist in-person assessments.
Frequently Asked Questions
What is ETNA-MS Device Validation Study?
ETNA-MS Device Validation Study is a clinical trial registered under NCT06256731. Current status: COMPLETED.
What is the status of NCT06256731?
The current status of NCT06256731 (ETNA-MS Device Validation Study) is: COMPLETED.
When did ETNA-MS Device Validation Study start?
ETNA-MS Device Validation Study started on 2023-12-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.